Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

60
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
60
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

92
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
92
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

124
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
124
Estimation of the Physical Quantities01:05

Estimation of the Physical Quantities

4.2K
On many occasions, physicists, other scientists, and engineers need to make estimates of a particular quantity. These are sometimes referred to as guesstimates, order-of-magnitude approximations, back-of-the-envelope calculations, or Fermi calculations. The physicist Enrico Fermi was famous for his ability to estimate various kinds of data with surprising precision. Estimating does not mean guessing a number or a formula at random. Instead, estimation means using prior experience and sound...
4.2K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

117
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum cryptography integrating an optical quantum memory.

Science advances·2025
Same author

Exploring interpretable echo analysis using self-supervised parcels.

Computers in biology and medicine·2025
Same author

The impact of imputation quality on machine learning classifiers for datasets with missing values.

Communications medicine·2023
Same author

Experimental cheat-sensitive quantum weak coin flipping.

Nature communications·2023
Same author

Beyond Maternal Tolerance: Education of Uterine Natural Killer Cells by Maternal MHC Drives Fetal Growth.

Frontiers in immunology·2022
Same author

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry.

Journal of visualized experiments : JoVE·2021

Related Experiment Video

Updated: Jun 26, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Improved clinical data imputation via classical and quantum determinantal point processes.

Skander Kazdaghli1, Iordanis Kerenidis1,2, Jens Kieckbusch3

  • 1QC Ware, Paris, France.

Elife
|May 9, 2024
PubMed
Summary

New determinantal point process (DPP) methods improve clinical data imputation for machine learning. These novel approaches enhance accuracy and provide reliable imputations, benefiting pharmaceutical drug trials.

Keywords:
clinicalcomputational biologycritical care unithumansurvivalsystems biology

More Related Videos

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jun 26, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Machine Learning
  • Computational Biology
  • Quantum Computing

Background:

  • Missing clinical data is a significant challenge in machine learning, particularly in life sciences.
  • Current imputation methods lack standardization and can introduce variance into downstream classification tasks.
  • Reliable data imputation is crucial for accurate predictive modeling in clinical settings.

Purpose of the Study:

  • To introduce novel imputation methods based on determinantal point processes (DPP).
  • To enhance existing imputation techniques like multivariate imputation by chained equations and MissForest.
  • To improve the accuracy and reliability of clinical data imputation for machine learning.

Main Methods:

  • Development of novel imputation methods utilizing determinantal point processes (DPP).
  • Enhancement of established imputation algorithms (e.g., multivariate imputation by chained equations, MissForest) with DPP.
  • Experimental validation using synthetic and real-world clinical datasets.
  • Application of quantum circuits for DPP sampling on quantum hardware.

Main Results:

  • DPP-based imputation methods demonstrated improved accuracy in downstream classification tasks.
  • The proposed methods provide deterministic and reliable imputations, reducing classification variance.
  • Competitive results were achieved using quantum algorithms for DPP sampling on up to 10 qubits.
  • Enhanced effectiveness and robustness in clinical data prediction modeling.

Conclusions:

  • Novel classical and quantum DPP-based imputation methods offer significant improvements over existing techniques.
  • These methods enhance the quality and reliability of clinical data imputation.
  • The approach provides higher confidence in predictions, valuable for high-precision applications like pharmaceutical drug trials.